Overview

A Study to Evaluate Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy Subjects

Status:
Withdrawn

Trial end date:
2007-10-01

Target enrollment:
0

Participant gender:
All

Summary

This study is a 4 period study to see if there is any interaction between Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy Thai Adult Subjects

Phase:

Phase 1

Accepts Healthy Volunteers?

Accepts Healthy Volunteers

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Oseltamivir
Zanamivir

Criteria

Inclusion criteria:

- Healthy Volunteer(s)confirmed by physical exam, clinical labs, ECGs, and vitals

- Must be woman of non-childbearing potential or willing to abstain from intercourse for
two weeks prior to study drug administration and throughout the study or be willing to
use two acceptable methods of birth control.

Exclusion criteria:

- Subjects with history of certain heart problems or subjects with Hepatitis B, C or
HIV.